Rambod Mozafari
1 , Kamran Alimoghaddam
1, Hamed Sotoude
2, Ali Asadollahi-Amin
3*1 Department of Hematology, Oncology, and Bone Marrow Transplantation, Dr. Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
2 Department of Emergency Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran
3 Iranian Research Center for HIV/AIDS (IRCHA), Tehran University of Medical Sciences, Tehran, Iran
Abstract
Myeloid sarcoma (MS) is a solid extra-medullary tumor of immature myeloid cells which could occur before, during or after
remission of acute leukemia at any site on the body. Owing to variation in differential diagnosis, pathologic evaluation and
immunohistochemical staining are essential for definitive diagnosis. Rarely, MS has been shown as an isolated extramedullary
relapse (iEMR) after allogeneic stem cell transplantation (allo-SCT), which often does not necessarily result in bone marrow
involvement. It seems that despite chemotherapy and graft-versus-leukemia (GVL) effects on bone marrow, leukemic cells could
remain alive in the extra-medullary region. However, in order to achieve longer survival, timely diagnosis as well as combined
systemic, local, and cellular therapeutic modalities should be considered in any patient with iEMR after allo-SCT.
We report a left lateral neck isolated MS presented as acute otitis externa in a patient with prior allo-SCT due to acute myeloid
leukemia (AML). Therefore, MS should be considered in patients with any history of acute leukemia even if the patient presents
with signs and symptoms of an infectious disease.